Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Jamie L. Eberling"'
Autor:
Alexandra C. Apple, Cutter A. Lindbergh, Susan M. Landau, Amy DeLuca, Jamie L. Eberling, William J. Jagust, Joel H. Kramer, Hope S. Rugo, Lara H. Heflin
Background. While breast cancer and its treatments may affect cognition, the longitudinal trajectories of cognition among those receiving differing cancer treatment types remain poorly understood. Prior research suggests hippocampal-prefrontal cortex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1797d9624f4c79fc01e22579471ef31
https://escholarship.org/uc/item/9cj1h6h9
https://escholarship.org/uc/item/9cj1h6h9
Autor:
Brian K. Fiske, Simon R.W. Stott, Mart Saarma, Camille Carroll, David Eidelberg, Roger A. Barker, Richard K. Wyse, Patrik Brundin, Amber D. Van Laar, Jamie L. Eberling, David T Dexter, Henri J. Huttunen, Merja H. Voutilainen, Adrian P. Kells, Jeffrey H. Kordower, Eros Bresolin, Alasdair Coles, Leah Mursaleen, Don M. Gash, Karl Kieburtz, Alan L Whone, Howard J. Federoff, A. Jon Stoessl, Sigrid Booms, Lyndsey Isaacs, Massimo S. Fiandaca, Anthony E. Lang, Codrin Lungu, Krystof S. Bankiewicz, Helen Matthews, Anders Björklund
Publikováno v:
Journal of Parkinson's disease, vol 10, iss 3
Barker, R A, Bjorklund, A, Gash, D M, Whone, A, Van Laar, A, Kordower, J H, Bankiewicz, K, Kieburtz, K, Saarma, M, Booms, S, Huttunen, H J, Kells, A, Fiandaca, M S, Stoessl, A J, Eidelberg, D, Federoff, H, Voutilainen, M, Dexter, D T, Eberling, J, Brundin, P, Isaacs, L, Mursaleen, L, Bresolin, E, Carroll, C, Coles, A, Fiske, B, Matthews, H, Lungu, C, Wyse, R K, Stott, S & Lang, A E 2020, ' GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop ', Journal of Parkinson's Disease, vol. 10, no. 3, pp. 875-891 . https://doi.org/10.3233/JPD-202004
Journal of Parkinson's Disease
Barker, R A, Bjorklund, A, Gash, D M, Whone, A, Van Laar, A, Kordower, J H, Bankiewicz, K, Kieburtz, K, Saarma, M, Booms, S, Huttunen, H J, Kells, A, Fiandaca, M S, Stoessl, A J, Eidelberg, D, Federoff, H, Voutilainen, M, Dexter, D T, Eberling, J, Brundin, P, Isaacs, L, Mursaleen, L, Bresolin, E, Carroll, C, Coles, A, Fiske, B, Matthews, H, Lungu, C, Wyse, R K, Stott, S & Lang, A E 2020, ' GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop ', Journal of Parkinson's Disease, vol. 10, no. 3, pp. 875-891 . https://doi.org/10.3233/JPD-202004
Journal of Parkinson's Disease
The concept of repairing the brain with growth factors has been pursued for many years in a variety of neurodegenerative diseases including primarily Parkinson's disease (PD) using glial cell line-derived neurotrophic factor (GDNF). This neurotrophic
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
Autor:
Liana S. Rosenthal, Hyunkeun Ryan Cho, Keith A. Hawkins, Michele K. York, Parkinson's Progression Markers Initiative, Tanya Simuni, Irene H. Richard, Dag Aarsland, Jamie L. Eberling, Daniel Weintraub, Alberto J. Espay, Roy N. Alcalay, Andrew Siderowf, James B. Leverenz, Jamie L. Hamilton, Irene Litvan, Lana M. Chahine, Christopher S. Coffey, Chelsea Caspell-Garcia, Matthew J. Barrett
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 4, Pp 449-461 (2020)
Annals of clinical and translational neurology, vol 7, iss 4
Annals of Clinical and Translational Neurology
Annals of clinical and translational neurology, vol 7, iss 4
Annals of Clinical and Translational Neurology
Author(s): Weintraub, Daniel; Caspell-Garcia, Chelsea; Simuni, Tanya; Cho, Hyunkeun R; Coffey, Christopher S; Aarsland, Dag; Alcalay, Roy N; Barrett, Matthew J; Chahine, Lana M; Eberling, Jamie; Espay, Alberto J; Hamilton, Jamie; Hawkins, Keith A; Le
Autor:
Jesse M. Cedarbaum, Johan Luthman, Samantha J. Hutten, Kalpana Merchant, Patrik Brundin, Alberto J. Espay, Monica Javidnia, Walter Maetzler, Kuldip D. Dave, Alyssa Reimer, Jamie L. Eberling, Liliana Menalled, David M Weiner, A. Jon Stoessl
Publikováno v:
Journal of Parkinson's Disease
The convergence of human molecular genetics and Lewy pathology of Parkinson's disease (PD) have led to a robust, clinical-stage pipeline of alpha-synuclein (α-syn)-targeted therapies that have the potential to slow or stop the progression of PD and
Autor:
John F. Crary, Thomas G. Beach, Christopher S. Coffey, Carlos Cordon-Cardo, John Koll, Geidy E. Serrano, Jamie L. Eberling, Nabil Tabish, Clare Bryce, Jack Zeineh, Brit Mollenhauer, Charles L. White, Gerardo Fernandez, Lindsey Riley, Bahram Marami, Kuldip D. Dave, Maxim Signaevski, Sherri Mosovsky, Marcel Prastawa, Charles H. Adler, Lana M. Chahine, Daniel Koenigsberg
Publikováno v:
Alzheimer's & Dementia. 16
Publikováno v:
Frontiers in Human Neuroscience, Vol 2 (2008)
Although positron emission tomography (PET) and the aromatic L-amino acid decarboxylase (AADC) tracer 6-[18F]fluoro-L-m-tyrosine (FMT) has been used to assess the integrity of the presynaptic dopamine system in the brain, relatively little has been p
Externí odkaz:
https://doaj.org/article/231a459be51b4816b5f99738914b1849
Autor:
Irene Litvan, Paolo Barone, Irene H. Richard, Matthew D. Troyer, Tanya Simuni, Alberto J. Espay, Eric D. Foster, James B. Leverenz, Keith A. Hawkins, David J. Burn, Lama M. Chahine, Christopher S. Coffey, Chelsea Caspell-Garcia, Jamie L. Eberling, Andrew Siderowf, Dag Aarsland, Shirley Lasch, Daniel Weintraub
Publikováno v:
Movement Disorders. 30:919-927
This study was undertaken to determine the prevalence and correlates of cognitive impairment (CI) and neuropsychiatric symptoms (NPS) in early, untreated patients with Parkinson’s disease (PD). Background Both CI and NPS are common in PD and impact
Autor:
Jennifer G. Goldman, Lona Vincent, Daniel Weintraub, Jamie L. Eberling, Glenn T. Stebbins, Karl Kieburtz, Jaime Kulisevsky, Connie Marras
Publikováno v:
Journal of Parkinsons Disease
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Cognitive impairment is a common occurrence in Parkinson's disease (PD), although the severity and specific presentation varies across patients. Initial deficits, including mild cognitive impairment (PD-MCI), may remain stable or in many cases, may p
Publikováno v:
Movement Disorders. 33:501-502
Publikováno v:
Biomarkers in Medicine. 4:723-729
Therapeutic development in Parkinson’s disease is hampered by the paucity of well-validated biomarkers that can assist with diagnosis and/or tracking the progression of the disease. Since its inception, the Michael J Fox Foundation for Parkinson’